Skip to main content
Robert Hasserjian, MD, Pathology, Boston, MA

RobertPaulHasserjianMD

Pathology Boston, MA

Hematopathology, Anatomic Pathology, Clinical Pathology

Associate Professor of Pathology, Massachusetts General Hospital

Dr. Hasserjian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hasserjian's full profile

Already have an account?

  • Office

    55 Fruit St
    Wrn 225
    Boston, MA 02114
    Phone+1 617-724-1445
    Fax+1 617-726-7474

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1990 - 1995
  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Hematopathology, 1992 - 1993
  • Harvard Medical School
    Harvard Medical SchoolClass of 1990

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1994 - 2025
  • NH State Medical License
    NH State Medical License 2015 - 2025
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Hematology

Publications & Presentations

PubMed

Journal Articles

  • Hematopoietic Neoplasms with 9p24/JAK2 Rearrangement: A Multicenter Study  
    Guilin Tang, Daniel A Arber, Elizabeth M Margolskee, Heesun J Rogers, Robert P Hasserjian, Eric D Hsi, Sa A Wang, Wayne Tam, Adam Bagg, Olga Weinberg, Jonathan I Lake,..., Nature

Abstracts/Posters

  • TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes
    Robert P. Hasserjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Bone Marrow Morphologic Findings in Patients Receiving IDH Inhibitor Therapy in Combination with Intensive Induction Chemotherapy: Challenges with Interpretation of th...
    Robert P. Hasserjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Diagnostic Algorithm for Lower-Risk Myelodysplastic Syndromes
    Robert Hasserjian, MD, Nature, Orlando, FL, 12/8/2019

Lectures

  • Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Mye... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Clinical, Immunophenotypic and Genomic Findings  of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow P... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Surgical Pathology for the Practicing Pathologist 
    Harvard Medical School, Scottsdale, Arizona - 1/14/2012

Press Mentions

  • Newly Characterized Mutation May Define a Novel Leukemia Subtype in Kids
    Newly Characterized Mutation May Define a Novel Leukemia Subtype in KidsFebruary 24th, 2022
  • Newly Characterized Mutation May Define Novel Pediatric AML Subtype
    Newly Characterized Mutation May Define Novel Pediatric AML SubtypeFebruary 17th, 2022
  • Case 7-2019: A 73-Year-Old Woman with Swelling of the Right Groin and Fever
    Case 7-2019: A 73-Year-Old Woman with Swelling of the Right Groin and FeverFebruary 28th, 2019